Products and services using Prenatal gene manipulation are generally available around 2024
Grader A: miss
Grader B: miss
agrees with A, without seeing its verdict
Audit: confirmed
in the fixed audit sample (D11)
Published: miss
Grader A: miss
The only known clinical use (He Jiankui, 2018) was a criminal act punished in 2019; germline editing is prohibited in China and under international guidelines, and no clinic offers it. Not available by 2026.
Test: D37 Horizons: prenatal genome editing offered to ordinary customers by 2026 for a hit; miss if not available by 2029.
Grader B: miss
Heritable human genome editing is banned or not authorised in the US, UK, EU and China after He Jiankui's 2018 experiment, which led to his imprisonment. No clinic offers it as of 2026. Window to 2029 is open.
Test: Ordinary customers could buy embryo/fetal genome editing by 2026; partial if limited (e.g. a licensed clinic) or by 2027-2029.